Improved antitumour immunity in murine neuroblastoma using a combination of IL-2 and IL-12

Neuroblastoma immunotherapy using cytokine-modified tumour cells has been tested in clinical trials. However, because of the complex nature of antitumour immune responses, a number of therapies may be required for complete tumour eradication and generation of systemic immunity. We report here the im...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Siapati, K E, Barker, S, Kinnon, C, Michalski, A, Anderson, R, Brickell, P, Thrasher, A J, Hart, S L
Format: Artigo
Langue:Inglês
Publié: Nature Publishing Group 2003
Sujets:
Experimental Therapeutics
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2377114/
https://ncbi.nlm.nih.gov/pubmed/12771934
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6600928
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires